Articles

Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide - an international collaborative study

Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany; NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg
NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg
Service des Maladies du Sang GH Sud, Amiens
5HCE Grenoble, Service d'Oncologie et Hématologie Pédiatrique, Grenoble
Department of Medicine III, Technical University of Munich
Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden, TU Dresden
Service d'Hématologie du Pr. Cahn Hopital Jean Minjoz, Besancon
Hospital Nord, Nurnberg
Service d'Hématologie, Hotel Dieu Nantes
Département d'Hématologie Clinique du Chu Saint Eloi Montpellier
Hôpital Saint Louis, Université Paris Diderot, Paris
Hôpital Saint Louis, Université Paris Diderot, Paris
Hôpital Saint Louis, Université Paris Diderot, Paris
Department of Internal Medicine 5 – Hematology/Oncology, University Hospital of Erlangen
Robert-Bosch-Hospital, Stuttgart
Service d'Hémato-Oncologie du Pr. Castaigne Hopital Andre Mignot le Chesnay
University Hospital Essen
Service des Maladies du Sang Chru, Hopital Claude Huriez, Lille
Klinik für Hämatologie, Onkologie und Palliativmedizin, Klinikum Bielefeld Mitte
University Hospital Aachen
Service de Médecine interne, Hématologie du Pr. Christian Chr Metz Thionville, Hopital de Marcy, Metz
Department of Hematology, Oncology and Tumor Immunology, Charité-University Medical Center, Campus Benjamin Franklin, Berlin
Angers University Hospital, Maladies du Sang, Angers; Fédération Hospitalo-Universitaire Grand-Ouest Acute Leukemia, FHU-GOAL, France; Université d'Angers, Inserm, CRCINA, Angers
Hôpital Avicenne, Assistance Publique - Hôpitaux de Paris, Université Paris
Hematology Department, Institut Paoli Calmettes, Marseille
Service d' Oncologie Médicale Hopital de la Source, Orleans
University Hospital of Würzburg
Service d'Hématologie, Hopital v.Provo, Roubaix
Vivantes Klinikum Neukölln, Berlin
Gemeinschaftsklinikum Mittelrhein gGmbH, Koblenz
Division of Hematology, Hôpital de Brabois, Centre Hospitalier Universitaire de Nancy, Nancy
Klinikum Offenburg
Service d' Hématologie, Thérapie Cellulaire du Pr. Bordessoule, Hopital Universitaire Dupuytren, Limoges
Service d'Hématologie du Dr. Sutton Centre Hospitalier v. Dupouy, Argenteuil
Service d'Hematologie Clinique, CH Sud Francilien, Corbeil Essonnes
Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg; German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg
Department of Medicine III - Hematology and Internal Oncology, University Hospital Regensburg, Regensburg
St. Vincentius Kliniken, Abteilung für Hämatologie, Onkologie, Immunologie und Palliativmedizin, Karlsruhe
Département d'Hématologie, Gustave Roussy, Université Paris-Saclay, Villejuif; INSERM Unit 1170, Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif
Department of Medicine III, University Hospital, Ludwig-Maximilians University (LMU) Munich, Munich
Department of Medicine III, University Hospital, Ludwig-Maximilians University (LMU) Munich, Munich
Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg
Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden, TU Dresden
Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden, TU Dresden
Department of Internal Medicine II, University Hospital of Frankfurt Main
Department of Medicine I, University Hospital Carl-Gustav-Carus, Dresden, TU Dresden
Department of Internal Medicine II, University Hospital of Kiel
Department of Hematology and Oncology, University Hospital Mannheim, Mannheim
Hôpital Saint Louis, Université Paris Diderot, Paris
Medical Clinic and Policlinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig
Hôpital Saint Louis, Université Paris Diderot, Paris
Haematologica Early view May 27, 2021 https://doi.org/10.3324/haematol.2021.278722